LR
Vaxxinity Pipeline
| Drug | Indication | Phase |
|---|---|---|
| UB-311 | Alzheimer's Disease | Phase 2 |
| UB-612 | COVID-19 Booster | Phase 3 |
| VXX-401 | Hypercholesterolemia | Phase 1 |
| VXX-301 | Parkinson's Disease | Preclinical |
| Undisclosed | Migraine Prevention | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| UB-311 | Alzheimer's Disease | Phase 2 |
| UB-612 | COVID-19 Booster | Phase 3 |
| VXX-401 | Hypercholesterolemia | Phase 1 |
| VXX-301 | Parkinson's Disease | Preclinical |
| Undisclosed | Migraine Prevention | Preclinical |